Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v3-FR Version v2-EN
Language French English
Date Updated 2017-03-14 2017-03-14
Drug Identification Number 02407728 02407728
Brand name SANDOZ QUETIAPINE XRT SANDOZ QUETIAPINE XRT
Common or Proper name QUETIAPINE XRT QUETIAPINE XRT
Company Name SANDOZ CANADA INCORPORATED SANDOZ CANADA INCORPORATED
Ingredients QUETIAPINE QUETIAPINE
Strength(s) 300MG 300MG
Dosage form(s) TABLET (EXTENDED-RELEASE) TABLET (EXTENDED-RELEASE)
Route of administration ORAL ORAL
Packaging size 300mg 100/Btl 300mg 100/Btl
ATC code N05AH N05AH
ATC description ANTIPSYCHOTICS ANTIPSYCHOTICS
Reason for shortage Demand increase for the drug. Demand increase for the drug.
Anticipated start date
Actual start date 2017-03-14 2017-03-14
Estimated end date 2017-04-30 2017-04-30
Actual end date
Shortage status Anticipated shortage Anticipated shortage
Tier 3 Status No No
Company comments
Health Canada comments